DK613989D0 - Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning - Google Patents

Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning

Info

Publication number
DK613989D0
DK613989D0 DK613989A DK613989A DK613989D0 DK 613989 D0 DK613989 D0 DK 613989D0 DK 613989 A DK613989 A DK 613989A DK 613989 A DK613989 A DK 613989A DK 613989 D0 DK613989 D0 DK 613989D0
Authority
DK
Denmark
Prior art keywords
tromotoric
preparation
gas
effect
substituted benzamides
Prior art date
Application number
DK613989A
Other languages
English (en)
Other versions
DK613989A (da
Inventor
Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Renee Gardaix-Luthereau
Brenda Costall
Robert Naylor
Original Assignee
Delagrange Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delagrange Lab filed Critical Delagrange Lab
Publication of DK613989D0 publication Critical patent/DK613989D0/da
Publication of DK613989A publication Critical patent/DK613989A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
DK613989A 1988-12-14 1989-12-06 Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning DK613989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8816433A FR2640139A1 (fr) 1988-12-14 1988-12-14 Application de benzamides substitues comme gastromoteurs

Publications (2)

Publication Number Publication Date
DK613989D0 true DK613989D0 (da) 1989-12-06
DK613989A DK613989A (da) 1990-06-15

Family

ID=9372914

Family Applications (1)

Application Number Title Priority Date Filing Date
DK613989A DK613989A (da) 1988-12-14 1989-12-06 Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning

Country Status (9)

Country Link
US (1) US5116857A (da)
EP (1) EP0374029B1 (da)
JP (1) JPH02237928A (da)
AT (1) ATE73997T1 (da)
CA (1) CA2005442A1 (da)
DE (1) DE68901085D1 (da)
DK (1) DK613989A (da)
FR (1) FR2640139A1 (da)
GR (1) GR3004350T3 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
US6662951B1 (en) * 2000-09-27 2003-12-16 Basic Resources, Inc. Process for extracting and purifying naturally occurring zeolite
PL2376075T3 (pl) * 2008-12-22 2015-08-31 Evoke Pharma Inc Donosowe preparaty z metoklopramidu
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
CA3047088A1 (en) 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281394A (da) * 1961-07-25
CA1082181A (en) * 1976-06-03 1980-07-22 Eric A. Watts Benzamide derivatives
US4188393A (en) * 1977-04-22 1980-02-12 Sandoz Ltd. Treating spastic conditions or relaxing muscles
US4714707A (en) * 1984-01-13 1987-12-22 Rorer Pharmaceutical Corporation Aryl substituted heterocycles for treating gastrointestinal motility dysfunction
EP0201537B1 (en) * 1984-10-23 1992-04-29 Nastech Pharmaceutical Company, Inc. Novel use of anti-nausea and anti-emetic pharmazeutical agents.
GB8519707D0 (en) * 1985-08-06 1985-09-11 Fordonal Sa Chemical compounds
FR2592042B1 (fr) * 1985-12-19 1988-03-25 Ile De France Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques
CZ284687B6 (cs) * 1986-04-30 1999-02-17 Dainippon Pharmaceutical Co., Ltd. Substituovaný benzamidový derivát, způsob jeho výroby a farmaceutický prostředek na jeho bázi
ATE82124T1 (de) * 1987-06-17 1992-11-15 Delagrange Lab Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel.
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides

Also Published As

Publication number Publication date
CA2005442A1 (fr) 1990-06-14
JPH02237928A (ja) 1990-09-20
EP0374029A1 (fr) 1990-06-20
EP0374029B1 (fr) 1992-03-25
ATE73997T1 (de) 1992-04-15
DE68901085D1 (de) 1992-04-30
US5116857A (en) 1992-05-26
FR2640139A1 (fr) 1990-06-15
DK613989A (da) 1990-06-15
GR3004350T3 (da) 1993-03-31

Similar Documents

Publication Publication Date Title
MX5680E (es) Procedimiento para la preparacion de 2-(2-alcoxietil)-2'-hidroxi-6,7-benzomorfanos
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
ES488788A0 (es) Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.
PT91575A (pt) Procede de preparation de benzylamines disubstituees utiles comme medicaments
DK613989A (da) Anvendelse af substituerede benzamider til fremstilling af laegemidler med gastromotorisk virkning
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DK640687A (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
ES2069719T3 (es) Nuevos derivados de tiofeno, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0424194T3 (da) Benzanilider
ZA911396B (en) Propanamines,their pharmacological properties and their application for therapeutic,in particular antidiarrhoeal,purposes
AT388373B (de) Neue thyroninderivate
DK0508955T3 (da) Anvendelse af 2-iminothiazolidin-4-onderivater som nye lægemidler
DK228086D0 (da) Substituerede isoxazol-derivater med antiviral virkning og fremgangsmaade af saadanne derivater
ES8107206A1 (es) Procedimiento para obtener derivados de tiazol
SE8400629L (sv) Basiska oximetrar
DK614089D0 (da) Anvendelse af substituerede benzamider til fremstilling af laegemidler med anxiolytisk og antipsykotisk virkning
FI910894A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten N-sykloalkyylialkyyliamiinien valmistamiseksi
SE7712447L (sv) Sett att framstella nya bensofenonderivat
DK0424248T3 (da) 20,21-dinoreburnamein med substitution i 15-stillingen, fremgangsmåde til deres fremstilling samt mellemprodukter til brug derved, deres anvendelse som lægemidler og præparater med indhold deraf
ES2068685T3 (es) Procedimiento de preparacion de nuevos derivados de 1,5-diin-cicloalquenos.
ATE36536T1 (de) Phosphoroimidate.
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment